Vertex Pharmaceuticals (VRTX) Shares Repurchased (2018 - 2026)

Vertex Pharmaceuticals' Shares Repurchased history runs 8 years deep, the most recent figure standing at $336.9 million for Q1 2026.

• In Q1 2026, Shares Repurchased fell 20.93% year-over-year to $336.9 million; the TTM figure through Mar 2026 stood at $1.9 billion (up 30.99% YoY), while the FY2025 annual figure was $2.0 billion, up 71.39% from the prior year.
• Shares Repurchased was $336.9 million for Q1 2026 at Vertex Pharmaceuticals, up from $128.4 million in the prior quarter.
• In the past five years, Shares Repurchased ranged from a high of $1.1 billion in Q3 2025 to a low of $28.3 million in Q2 2023.
• Historically, Shares Repurchased has averaged $304.5 million across 4 years, with a median of $307.7 million in 2024.
• The sharpest annual moves came in 2024 and 2025: Shares Repurchased surged 1031.8% in 2024, then slumped 69.27% in 2025.
• A 4-year view of Shares Repurchased shows it stood at $149.5 million in 2023, then soared by 179.53% to $417.9 million in 2024, then plunged by 69.27% to $128.4 million in 2025, then surged by 162.38% to $336.9 million in 2026.
• The last three Shares Repurchased figures came in at $336.9 million (Q1 2026), $128.4 million (Q4 2025), and $1.1 billion (Q3 2025), per Business Quant data.